PMC:7335494 / 70775-71086 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T769","span":{"begin":236,"end":239},"obj":"http://purl.obolibrary.org/obo/CL_0000232"}],"text":"5-month intervention:➢ 300 mg EPA + DHA/day\n➢ 600 mg EPA + DHA/day\n➢ 900 mg EPA + DHA/day\n➢ 1800 mg EPA + DHA/day\n➢ placebo 125 No significant effect on IL-6 or CPR;Marginal effect on TNF-α observed at the highest dose (1800 mg) Higher RBC DHA was associated with lower TNF-α concentrations. Flock et al. (2014)"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T742","span":{"begin":30,"end":33},"obj":"Chemical"},{"id":"T743","span":{"begin":36,"end":39},"obj":"Chemical"},{"id":"T747","span":{"begin":53,"end":56},"obj":"Chemical"},{"id":"T748","span":{"begin":59,"end":62},"obj":"Chemical"},{"id":"T752","span":{"begin":76,"end":79},"obj":"Chemical"},{"id":"T753","span":{"begin":82,"end":85},"obj":"Chemical"},{"id":"T757","span":{"begin":100,"end":103},"obj":"Chemical"},{"id":"T758","span":{"begin":106,"end":109},"obj":"Chemical"},{"id":"T762","span":{"begin":153,"end":155},"obj":"Chemical"},{"id":"T764","span":{"begin":240,"end":243},"obj":"Chemical"}],"attributes":[{"id":"A742","pred":"chebi_id","subj":"T742","obj":"http://purl.obolibrary.org/obo/CHEBI_28364"},{"id":"A743","pred":"chebi_id","subj":"T743","obj":"http://purl.obolibrary.org/obo/CHEBI_16016"},{"id":"A744","pred":"chebi_id","subj":"T743","obj":"http://purl.obolibrary.org/obo/CHEBI_28125"},{"id":"A745","pred":"chebi_id","subj":"T743","obj":"http://purl.obolibrary.org/obo/CHEBI_28689"},{"id":"A746","pred":"chebi_id","subj":"T743","obj":"http://purl.obolibrary.org/obo/CHEBI_36005"},{"id":"A747","pred":"chebi_id","subj":"T747","obj":"http://purl.obolibrary.org/obo/CHEBI_28364"},{"id":"A748","pred":"chebi_id","subj":"T748","obj":"http://purl.obolibrary.org/obo/CHEBI_16016"},{"id":"A749","pred":"chebi_id","subj":"T748","obj":"http://purl.obolibrary.org/obo/CHEBI_28125"},{"id":"A750","pred":"chebi_id","subj":"T748","obj":"http://purl.obolibrary.org/obo/CHEBI_28689"},{"id":"A751","pred":"chebi_id","subj":"T748","obj":"http://purl.obolibrary.org/obo/CHEBI_36005"},{"id":"A752","pred":"chebi_id","subj":"T752","obj":"http://purl.obolibrary.org/obo/CHEBI_28364"},{"id":"A753","pred":"chebi_id","subj":"T753","obj":"http://purl.obolibrary.org/obo/CHEBI_16016"},{"id":"A754","pred":"chebi_id","subj":"T753","obj":"http://purl.obolibrary.org/obo/CHEBI_28125"},{"id":"A755","pred":"chebi_id","subj":"T753","obj":"http://purl.obolibrary.org/obo/CHEBI_28689"},{"id":"A756","pred":"chebi_id","subj":"T753","obj":"http://purl.obolibrary.org/obo/CHEBI_36005"},{"id":"A757","pred":"chebi_id","subj":"T757","obj":"http://purl.obolibrary.org/obo/CHEBI_28364"},{"id":"A758","pred":"chebi_id","subj":"T758","obj":"http://purl.obolibrary.org/obo/CHEBI_16016"},{"id":"A759","pred":"chebi_id","subj":"T758","obj":"http://purl.obolibrary.org/obo/CHEBI_28125"},{"id":"A760","pred":"chebi_id","subj":"T758","obj":"http://purl.obolibrary.org/obo/CHEBI_28689"},{"id":"A761","pred":"chebi_id","subj":"T758","obj":"http://purl.obolibrary.org/obo/CHEBI_36005"},{"id":"A762","pred":"chebi_id","subj":"T762","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A763","pred":"chebi_id","subj":"T762","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A764","pred":"chebi_id","subj":"T764","obj":"http://purl.obolibrary.org/obo/CHEBI_16016"},{"id":"A765","pred":"chebi_id","subj":"T764","obj":"http://purl.obolibrary.org/obo/CHEBI_28125"},{"id":"A766","pred":"chebi_id","subj":"T764","obj":"http://purl.obolibrary.org/obo/CHEBI_28689"},{"id":"A767","pred":"chebi_id","subj":"T764","obj":"http://purl.obolibrary.org/obo/CHEBI_36005"}],"text":"5-month intervention:➢ 300 mg EPA + DHA/day\n➢ 600 mg EPA + DHA/day\n➢ 900 mg EPA + DHA/day\n➢ 1800 mg EPA + DHA/day\n➢ placebo 125 No significant effect on IL-6 or CPR;Marginal effect on TNF-α observed at the highest dose (1800 mg) Higher RBC DHA was associated with lower TNF-α concentrations. Flock et al. (2014)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T411","span":{"begin":0,"end":43},"obj":"Sentence"},{"id":"T412","span":{"begin":44,"end":66},"obj":"Sentence"},{"id":"T413","span":{"begin":67,"end":89},"obj":"Sentence"},{"id":"T414","span":{"begin":90,"end":113},"obj":"Sentence"},{"id":"T415","span":{"begin":114,"end":291},"obj":"Sentence"},{"id":"T416","span":{"begin":292,"end":311},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"5-month intervention:➢ 300 mg EPA + DHA/day\n➢ 600 mg EPA + DHA/day\n➢ 900 mg EPA + DHA/day\n➢ 1800 mg EPA + DHA/day\n➢ placebo 125 No significant effect on IL-6 or CPR;Marginal effect on TNF-α observed at the highest dose (1800 mg) Higher RBC DHA was associated with lower TNF-α concentrations. Flock et al. (2014)"}

{"project":"MyTest","denotations":[{"id":"32640331-25091379-30720992","span":{"begin":306,"end":310},"obj":"25091379"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"5-month intervention:➢ 300 mg EPA + DHA/day\n➢ 600 mg EPA + DHA/day\n➢ 900 mg EPA + DHA/day\n➢ 1800 mg EPA + DHA/day\n➢ placebo 125 No significant effect on IL-6 or CPR;Marginal effect on TNF-α observed at the highest dose (1800 mg) Higher RBC DHA was associated with lower TNF-α concentrations. Flock et al. (2014)"}

{"project":"2_test","denotations":[{"id":"32640331-25091379-30720992","span":{"begin":306,"end":310},"obj":"25091379"}],"text":"5-month intervention:➢ 300 mg EPA + DHA/day\n➢ 600 mg EPA + DHA/day\n➢ 900 mg EPA + DHA/day\n➢ 1800 mg EPA + DHA/day\n➢ placebo 125 No significant effect on IL-6 or CPR;Marginal effect on TNF-α observed at the highest dose (1800 mg) Higher RBC DHA was associated with lower TNF-α concentrations. Flock et al. (2014)"}